Minimal Residual Disease in Melanoma:molecular characterization of in transit cutaneous metastases and Circulating Melanoma Cells recognizes an expression panel potentially related to disease progression-Reference-Cited by-同舟云学术

Minimal Residual Disease in Melanoma:molecular characterization of in transit cutaneous metastases and Circulating Melanoma Cells recognizes an expression panel potentially related to disease progression

Published:2020 Issue: Volume:25 Page:100262
ISSN:2468-2942
Container-title:Cancer Treatment and Research Communications
language:en
Short-container-title:Cancer Treatment and Research Communications

Author:

Rapanotti Maria Cristina,Viguria Tara Mayte Suarez,Spallone Giulia,Terrinoni Alessandro,Rossi Piero,Costanza Gaetana,Campione Elena,Lombardo Paolo,Pathirannehalage Cristine Don,Orlandi Augusto,Bernardini Sergio,Bianchi Luca

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference91 articles.

1. Circulating tumour cells (CTC detection: clinical impact and future directions);Paterlini-Brechot;Cancer Lett.,2007

2. Circulating tumor cells: the ‘leukemic phase’ of solid cancers;Mocellin;Trends Mol. Med.,2006

3. Molecular detection of micrometastases and circulating tumour cells in solid tumors;Ghossein;Clin. Cancer Res.,1999

4. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases;Luzzi;Am. J. Pathol.,1998

5. Adhesion, migration and communication in melanocytes and melanoma;Haass;Pigment Cell Res.,2005

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epithelial-to-Mesenchymal Transition Gene Signature in Circulating Melanoma Cells: Biological and Clinical Relevance;International Journal of Molecular Sciences;2023-07-22

2. MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy;International Journal of Molecular Sciences;2021-11-17